Know Cancer

or
forgot password


Phase 2
18 Years
N/A
Not Enrolling
Both
Mesothelioma

Thank you

Trial Information


Inclusion Criteria:



- Have a proven diagnosis of malignant mesothelioma in patients not candidates for
curative surgery

- Prior chemotherapy for your disease is allowed

- Measurable lesion is not required

- Have a adequate performance status

- Sign an informed consent form

Exclusion Criteria:

- You are excluded from this trial if you have received any investigational agent
within 4 week before enrolling in this study

- You are excluded from this trial if you have received radiation within the previous 2
weeks

- You are excluded from this trial if you are a candidates for curative surgery

Type of Study:

Expanded Access

Study Design:

N/A

Authority:

United States: Food and Drug Administration

Study ID:

6093

NCT ID:

NCT00040625

Start Date:

Completion Date:

Related Keywords:

  • Mesothelioma
  • Mesothelioma

Name

Location

For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.Basking Ridge, New Jersey